Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Oncogenic osteomalacia--a complex dance of factors.

Carpenter TO.

N Engl J Med. 2003 Apr 24;348(17):1705-8. No abstract available.

PMID:
12711747
2.

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Jüppner H.

N Engl J Med. 2003 Apr 24;348(17):1656-63.

3.

[Tumor-induced rickets/osteomalacia].

Fukumoto S.

Nihon Rinsho. 2006 Jun 28;Suppl 2:96-9. Review. Japanese. No abstract available.

PMID:
16817359
4.

[Tumor-induced rickets/osteomalacia].

Fukumoto S.

Nihon Rinsho. 2005 Oct;63 Suppl 10:523-8. Review. Japanese. No abstract available.

PMID:
16279694
5.

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

Fukumoto S, Yamashita T.

N Engl J Med. 2003 Jul 31;349(5):505-6; author reply 505-6. No abstract available.

PMID:
12892105
6.

Tumor-induced osteomalacia.

Hewison M.

Curr Opin Rheumatol. 1994 May;6(3):340-4. Review.

PMID:
8060772
7.

Renal phosphate--wasting disorders in childhood.

Ward LM.

Pediatr Endocrinol Rev. 2005 Feb;2 Suppl 3:342-50. Review.

PMID:
16456503
8.

[Tumor-induced hypophosphatemic osteomalacia].

Ito N, Fukukmoto S.

Nihon Naika Gakkai Zasshi. 2007 Apr 10;96(4):731-6. Review. Japanese. No abstract available.

PMID:
17506312
9.

[Assay methods for FGF].

Ito N, Fukumoto S.

Nihon Rinsho. 2005 Oct;63 Suppl 10:498-502. Review. Japanese. No abstract available.

PMID:
16279689
10.

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

Kida Y.

N Engl J Med. 2003 Jul 31;349(5):505-6; author reply 505-6. No abstract available.

11.

[FGF23 (phosphatonin)].

Fukumoto S.

Nihon Rinsho. 2005 Aug;63 Suppl 8:606-8. Review. Japanese. No abstract available.

PMID:
16149589
12.

[FGF-23].

Miyauchi A.

Nihon Rinsho. 2004 Feb;62 Suppl 2:378-84. Review. Japanese. No abstract available.

PMID:
15035156
13.

[Autosomal dominant hypophosphatemic rickets/osteomalacia].

Tanaka H.

Nihon Rinsho. 2005 Oct;63 Suppl 10:529-33. Review. Japanese. No abstract available.

PMID:
16279695
14.

[Hypophosphatemic osteomalacia].

Bullmann C, Benker G, Rosien U, Delling G, Siggelkow H, Schulte HM.

Med Klin (Munich). 2008 Sep 15;103(9):671-5. doi: 10.1007/s00063-008-1106-z. Epub 2008 Sep 24. German.

PMID:
18813890
15.

Oncogenic osteomalacia, a rare paraneoplastic syndrome due to phosphate wasting--a case report and review of the literature.

Woznowski M, Quack I, Stegbauer J, Büchner N, Rump LC, Schieren G.

Clin Nephrol. 2008 Nov;70(5):431-8. Erratum in: Clin Nephrol. 2008 Dec;70(6):564.

PMID:
19000546
16.

Tumor-induced osteomalacia.

Jan de Beur SM.

JAMA. 2005 Sep 14;294(10):1260-7.

PMID:
16160135
17.

Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.

Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, Minagawa M, Sugimoto T, Yamauchi M, Michigami T, Matsumoto T.

Bone. 2008 Jun;42(6):1235-9. doi: 10.1016/j.bone.2008.02.014. Epub 2008 Mar 5.

PMID:
18396126
18.

Elevated fibroblast growth factor 23 in a patient with metastatic prostate cancer and hypophosphatemia.

Cotant CL, Rao PS.

Am J Kidney Dis. 2007 Dec;50(6):1033-6. No abstract available.

PMID:
18037105
19.

[Hypophosphatemia and tumor-induced osteomalacia].

van der Rest C, Cavalier E, Colson L, Kaux JF, Krzesinski JM, Reginster JY, Hustinx R, Delanaye P.

Rev Med Suisse. 2011 Aug 31;7(306):1630-3. French.

PMID:
21972729
20.

[Fibroblast growth factor 23--a phosphate regulating hormone].

Beck-Nielsen SS, Pedersen SM, Kassem M, Rasmussen LM.

Ugeskr Laeger. 2010 May 17;172(20):1521-7. Review. Danish.

PMID:
20483099

Supplemental Content

Support Center